Fundraising Fox

Forcyte Biotechnologies

YC W21 ↗

Los Angeles, US · Founded 2017 · Delaware corporation · 5 employees · Inactive · 3 known investors

forcytebio.com ↗

Forcyte Biotechnologies develops drug screening tools that measure cell contractility to identify therapeutic candidates for diseases driven by abnormal cellular force generation, such as asthma, fibrosis, and hypertension.

HealthtechMedical DevicesDrug discoveryin /forcyte-biotechnologies-inc@dinodicarloycombinator.com ↗

Founders & leadership· Y Combinator alumni (W21)

IPIvan Pushkarsky
Ivan PushkarskyinFounder
DDDino Di Carlo
Dino Di Carloin𝕏Founder

Investors · 3

Sprint VcBangalore · $300
Y CombinatorSan Francisco · $500K
Acequia CapitalreportedSeattle

Reported raises · per SEC filings

Form D private placements
▶$160KraisedJan 2019 · 3 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ivan PushkarskyExecutive Officer
Offering amount
$2M
Amount sold
$160K
Minimum investment
$25K
First sale
Dec 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news